Équilibre Biopharmaceuticals

0 followers


Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications.

Industries

Headquarters

Stage

Employees

Links

Org chart

Philip A. Barach
Chairman & CEO

Philip A. Barach

Collapse
Steven Gordon
Chief Operating Officer, Chief Legal & Compliance Officer
Amy Melsaether
SVP of Clinical Research
Alexandra Zanin-Zhorov
SVP of Translational Medicine
Meg Dodge
SVP of Corporate Strategy & Investor Relations
Kevin McCracken
SVP, Chemistry, Manufacturing & Controls
Bijan Bayat
SVP, Project Management
Julie Seiffert
SVP, Manufacturing & Compliance
Debra Maierhofer
VP of Pharmacovigilance & Medical Affairs
Justin Stebbing
Medical Strategist
Sumera Younis
VP, Regulatory Affairs